Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.37% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.41% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Smith Micro Software
SMSI
$16M
| $1.06M | ﹤0.01% |
21,908
+6,845
| +45% | +$359K |
|
2252
Babcock & Wilcox
BW
$1.53B
| $1.06M | ﹤0.01% |
251,438
+156,130
| +164% | +$815K |
|
2253
BayCom
BCML
$339M
| $1.06M | ﹤0.01% |
55,000
+4,800
| +10% | +$90.8K |
|
2254
Kura Oncology
KURA
$964M
| $1.05M | ﹤0.01% |
115,600
-72,500
| -39% | -$736K |
|
2255
iShares MSCI Indonesia ETF
EIDO
$489M
| $1.05M | ﹤0.01% |
+47,300
| New | +$1.09M |
|
2256
Sutro Biopharma
STRO
$340M
| $1.05M | ﹤0.01% |
30,290
+3,340
| +12% | +$146K |
|
2257
Cumberland Pharmaceuticals
CPIX
$117M
| $1.05M | ﹤0.01% |
555,763
-4,980
| -0.9% | -$8.35K |
|
|
NWLI
2258
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $1.05M | ﹤0.01% |
2,400
-300
| -11% | -$132K |
|
2259
IRIDEX
IRIX
$14.9M
| $1.05M | ﹤0.01% |
413,060
-6,100
| -1% | -$11.6K |
|
|
LX
2260
LexinFintech Holdings
LX
$224M
| $1.05M | ﹤0.01% |
473,674
+199,777
| +73% | +$482K |
|
|
ITI
2261
DELISTED
Iteris, Inc.
ITI
| $1.05M | ﹤0.01% |
252,785
+25,100
| +11% | +$107K |
|
|
MPX
2262
DELISTED
Marine Products Corp
MPX
| $1.05M | ﹤0.01% |
73,602
+11,500
| +19% | +$180K |
|
2263
Lifestance Health
LFST
$4.75B
| $1.04M | ﹤0.01% |
152,000
+100,178
| +193% | +$812K |
|
2264
Huntsman Corp
HUN
$1.81B
| $1.04M | ﹤0.01% |
42,700
-176,000
| -80% | -$4.77M |
|
2265
Mastech Digital
MHH
$94.7M
| $1.04M | ﹤0.01% |
115,727
-16,100
| -12% | -$167K |
|
2266
Peoples Financial Services
PFIS
$714M
| $1.04M | ﹤0.01% |
25,981
+700
| +3% | +$31.4K |
|
2267
Avita Medical
RCEL
$243M
| $1.04M | ﹤0.01% |
71,200
-28,800
| -29% | -$487K |
|
2268
Avantis US Small Cap Value ETF
AVUV
$31.2B
| $1.04M | ﹤0.01% |
13,300
-900
| -6% | -$72.3K |
|
|
SBDS
2269
DELISTED
Solo Brands Inc
SBDS
| $1.04M | ﹤0.01% |
5,078
-1,895
| -27% | -$413K |
|
|
APLT
2270
DELISTED
Applied Therapeutics
APLT
| $1.03M | ﹤0.01% |
415,478
+8,100
| +2% | +$13.4K |
|
2271
Flexible Solutions
FSI
$64.2M
| $1.03M | ﹤0.01% |
380,245
-12,800
| -3% | -$34.8K |
|
2272
VanEck Vietnam ETF
VNM
$496M
| $1.03M | ﹤0.01% |
76,200
-62,400
| -45% | -$908K |
|
2273
Protalix BioTherapeutics
PLX
$179M
| $1.03M | ﹤0.01% |
621,100
-38,200
| -6% | -$68.6K |
|
2274
Community Bank
CBU
$3.46B
| $1.03M | ﹤0.01% |
+24,408
| New | +$1.16M |
|
|
ALYA
2275
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
| $1.03M | ﹤0.01% |
681,133
-5,100
| -0.7% | -$9.12K |
|
Similar funds
Jim Simons's Q3 2023 Portfolio in Review
As of Q3 2023, Jim Simons held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.34B in Q3 2023, closing 713 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in D.R. Horton worth $125M.
- Jim Simons's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Jim Simons added most to Netflix in Q3 2023, an estimated $385M increase.
- Jim Simons's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Jim Simons fully exited Chevron in Q3 2023, selling an estimated $185M.
- Jim Simons's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Jim Simons opened 464 new positions and closed 713 in Q3 2023.
- Jim Simons's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.